Approval of the European Joint Programme on Rare Diseases Horizon2020 grant proposal

A new collaboration enables new cell therapy treatments for HUS patients

EATRIS Annual Report 2017

The future of Translational Medicine by Toni Andreu

A Retrospective look at EATRIS during its first 5 years

Successful RItrain Knowledge Exchange workshop hosted by EATRIS

Public consultation: Evaluation of the European Medicines Agency Fee System

Unique hub collaboration – Imaging method development in inflammatory diseases

Long term partnership between EATRIS sites and GSK.

ECaDE interview published online

Win a trip to Down Under including your ticket to AusBiotech 2018

CORBEL 2nd Open Call: Apply for Research Infrastructures Services

Transnational network for personalised medicine launches

EMA releases draft guideline on Safety and Efficacy (S&E) follow-up, and risk management for Advanced Therapy Medicinal Products (ATMPs).

EMA updates procedural advice to clarify regulatory process for Advanced Therapy Medicinal Products

ID-EPTRI: a new research infrastructure for better paediatric medicines emerges

2nd open call for RItrain knowledge exchange – profit from the expertise of other Research Infrastructures

New funding opportunity for neurodegenerative disease launched by NeurATRIS

Sweden begins the year by becoming a full member